Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 193M 586M 168M 159M 144M 270M 18.52B 271M 1.9B 734M 9.41B 725M 709M 30.29B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 329M 1B 287M 271M 246M 461M 31.6B 463M 3.25B 1.25B 16.07B 1.24B 1.21B 51.69B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 01/03/2020 |
Itai Kabiljo
LAW | General Counsel | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 03/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 14/12/2014 |
| Chairman | 55 | 13/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 63.54M | |
| 0.00% | -1.39% | +7.98% | +222.76% | 347M | |
| -3.36% | 0.00% | -40.98% | -32.08% | 145M | |
| +0.50% | +0.50% | +13.64% | +100.00% | 141M | |
| -1.00% | -2.94% | -25.00% | -58.05% | 101M | |
| +0.43% | +0.93% | -36.68% | -49.46% | 63.54M | |
| Average | -0.53% | -0.58% | -16.21% | +36.64% | 159.49M | |
| Weighted average by Cap. | -0.55% | -0.81% | -7.64% | +97.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 725M 208M 197M 179M 335M 22.92B 336M 2.36B 909M 11.65B 897M 877M 37.49B | 270M 821M 236M 222M 202M 379M 25.93B 380M 2.66B 1.03B 13.18B 1.02B 992M 42.41B |
| Net income | -67.8M -206M -59.12M -55.82M -50.69M -94.97M -6.51B -95.37M -669M -258M -3.31B -255M -249M -10.64B | -35.71M -108M -31.14M -29.4M -26.7M -50.02M -3.43B -50.23M -352M -136M -1.74B -134M -131M -5.61B |
| Net Debt | 133M 403M 116M 109M 99.26M 186M 12.74B 187M 1.31B 505M 6.48B 499M 488M 20.84B | 136M 414M 119M 112M 102M 191M 13.08B 192M 1.34B 519M 6.65B 512M 501M 21.4B |
Employees
-
